Skip to Content

Haegarda (C1 esterase inhibitor (human)) Disease Interactions

There is 1 disease interaction with Haegarda (C1 esterase inhibitor (human)):


C1 esterase inhibitor, human (applies to Haegarda) thromboembolic events

Moderate Potential Hazard, Moderate plausibility. Applicable conditions: History - Thrombotic/Thromboembolic Disorder

Serious arterial and venous thromboembolic (TE) events have been reported at the recommended dose of C1 Esterase Inhibitor (Human) products. Benefits of C1 Esterase Inhibitor (Human) products for routine prophylaxis of hereditary angioedema attacks should be weighed against the risks of TE events in patients with underlying risk factors. It is recommended to monitor patients with known risk factors for thrombotic events.

Haegarda (C1 esterase inhibitor (human)) drug interactions

There are 44 drug interactions with Haegarda (C1 esterase inhibitor (human))

Drug Interaction Classification

These classifications are only a guideline. The relevance of a particular drug interaction to a specific individual is difficult to determine. Always consult your healthcare provider before starting or stopping any medication.
Major Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.
Moderate Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.
Minor Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.
Unknown No interaction information available.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.